| Literature DB >> 28929828 |
Oystein Gothesen1,2,3, Stein Hakon L Lygre1,4, Michelle Lorimer5, Stephen Graves5, Ove Furnes1,2.
Abstract
Background and purpose - Given similar functional outcomes with mobile and fixed bearings, a difference in survivorship may favor either. This study investigated the risk of aseptic loosening for the most used subtypes of mobile-bearing rotating-platform knees, in Norway and Australia. Patients and methods - Primary TKRs reported to the Norwegian and Australian joint registries, between 2003 and 2014, were analyzed with aseptic loosening as primary end-point and all revisions as secondary end-point. We hypothesized that no difference would be found in the rate of revision between rotating-platform and the most used fixed-bearing TKRs, or between keeled and non-keeled tibia. Kaplan-Meier estimates and curves, and Cox regression relative risk estimates adjusted for age, sex, and diagnosis were used for comparison. Results - The rotating-platform TKRs had an increased risk of revision for aseptic loosening compared with the most used fixed-bearing knees, in Norway (RR =6, 95% CI 4-8) and Australia (RR =2.1, 95% CI 1.8-2.5). The risk of aseptic loosening as a reason for revision was highest in Norway compared with Australia (RR =1.7, 95% CI 1.4-2.0). The keeled tibial component had the same risk of aseptic loosening as the non-keeled tibia (Australia). Fixation method and subtypes of the tibial components had no impact on the risk of aseptic loosening in these mobile-bearing knees. Interpretation - The rotating-platform TKRs in this study appeared to have a higher risk of revision for aseptic loosening than the most used fixed-bearing TKRs.Entities:
Mesh:
Year: 2017 PMID: 28929828 PMCID: PMC5694810 DOI: 10.1080/17453674.2017.1378533
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Demographics of included primary TKRs in Norway and Australia
| Study group | Control group | |||||
|---|---|---|---|---|---|---|
| mobile-bearing TKRs | fixed-bearing TKRs | |||||
| Norway | Australia | p-value | Norway | Australia | p-value | |
| Number | 12,003 | 31,522 | 19,580 | 48,173 | ||
| Men (%) | 36 | 45 | < 0.01 | 36 | 45 | < 0.01 |
| Age years (SD) | 68.7 (9.6) | 68.0 (9.3) | < 0.01 | 69.2 (9.7) | 68.3 (9.2) | < 0.01 |
| Primary diagnosis (%) | ||||||
| Primary osteoarthritis | 91 | 98 | 89 | 99 | < 0.01 | |
| Other | 9 | 2 | 11 | 1 | ||
| Fixation, n (%) | ||||||
| Cemented | 9,615 (81) | 5,999 (19) | 14,732 (76) | 21,425 (45) | ||
| Cementless | 1,362 (11) | 18,377 (58) | 1,062 (5) | 10,126 (21) | ||
| Hybrid (cemented tibia) | 975 (8) | 6,767 (22) | 3,674 (19) | 16,551 (34) | ||
| Hybrid (cementless tibia) | 3 (0) | 379 (1) | 22 (0) | 71 (0) | ||
| Missing | 48 | 0 | 90 | 0 | ||
| Mobile-bearing subtype tibia | ||||||
| LCS Complete | 12,003 | 31,522 | ||||
| No keel, n (%) | 10,764 (90) | 15,415 (49) | ||||
| Keel, n (%) | 1,148 (10) | 3,208 (10) | ||||
| Duo-fix, n (%) | 91 (0) | 12,899 (41) | ||||
| Controls | ||||||
| AGC, n (%) | 1,622 (8) | |||||
| NexGen, n (%) | 5,347 (27) | 16,609 (35) | ||||
| PFC Sigma, n (%) | 9,231 (19) | |||||
| Profix, n (%) | 12,611 (65) | |||||
| Triathlon, n (%) | 22,333 (46) | |||||
| Computer navigation, n (%) | 1,684 (14) | 2,384 (8) | 1,722 (10) | 11,286 (23) | ||
Study group: Mobile bearing knees with an LCS Complete tibial component catalogue numbers 12943 or 9003. Control group: 3 most used fixed-bearing, cruciate-retaining TKRs without patella resurfacing, in Norway and Australia.
P-values are generated on the basis of differences between groups using chi-square test for sex and diagnosis, and independent samples t-test for age difference.
LCS Complete (also called LCS MBT) and PFC Sigma have identical tibial components (cat. no: 1294-31/32 (no-keel) and 1294-33/34 (keel)). The Duo-fix version has cat. no: 9003. For simplicity this component is called LCS Complete in this paper.
Figure 1.Selection of study and control groups from the Norwegian and Australian joint replacement registries, 2003–2014.
Mobile-bearing brands (LCS and PFC Sigma).
Fixed-bearing cruciate-retaining brands, 3 most used in Norway (Profix, NexGen, AGC) and in Australia (Triathlon, NexGen, PFC Sigma).
Other tibial component catalogue numbers than 12943 and 9003.
TKR = total knee replacement. CR = cruciate retaining. PS = posterior stabilized.
Cat. no. = catalogue number.
K–M survival (not revised due to aseptic loosening) by LCS Complete tibial design and fixation method, of primary cruciate-retaining TKRs without patella resurfacing, reported to the Norwegian and Australian joint replacement registries between 2003 and 2014. K–M survival estimate was not calculated when median follow-up was less than a year, number of patients in the group was less than 100, or when number of patients at risk was less than 50. Relative risk (RR) for aseptic loosening estimated by Cox regression analysis adjusting for age, sex, and preoperative diagnosis, RR1 with Australian non-keeled as reference, RR2 with reference to country-specific control group (3 most used fixed bearings).
| Country | Implant type | Tibial | Total (n) | Revised | Median | K–M survival | At risk (n) | Cox RR 1 | Cox RR2 |
|---|---|---|---|---|---|---|---|---|---|
| Australia | |||||||||
| Control | Fixed bearing | Any fixation | 48,173 | 195 (4) | 3.4 | 99.0 (98.8–99.2) | 1,170 | 1 (ref.) | |
| Study | Mobile bearing | Any fixation | 31,522 | 354 (11) | 98.2 (98.0–98.4) | 2,867 | 2.1 (1.8–2.5) | ||
| Non-keeled | Any fixation | 15,415 | 143 (9) | 4.3 | 98.3 (97.9–98.7) | 1,059 | 1 (ref.) | 2.0 (1.6–2.4) | |
| Cemented | 9,541 | 78 (8) | 5.1 | 98.4 (98.0–98.8) | 776 | 1.7 (1.3–2.2) | |||
| Cementless | 5,874 | 65 (11) | 2.8 | 98.1 (97.5–98.7) | 373 | 2.5 (1.9–3.3) | |||
| Keeled | Any fixation | 3,208 | 35 (11) | 5.5 | 98.3 (97.7–98.9) | 510 | 1.0 (0.7–1.5) | 2.0 (1.4–2.9) | |
| Cemented | 3,206 | 35 (11) | 5.5 | 97.6 (96.0–99.2) | 139 | 1.0 (0.7–1.5) | 2.0 (1.4–2.9) | ||
| Cementless | 2 | 0 | 5.7 | – | – | – | – | ||
| Duo-fix | Any fixation | 12,899 | 176 (14) | 6.2 | 98.2 (97.8–98.6) | 2,891 | 1.1 (0.9–1.4) | 2.2 (1.8–2.8) | |
| Cemented | 19 | 0 | 7.3 | – | – | – | – | ||
| Cementless | 12,880 | 176 (14) | 6.2 | 98.1 (97.7–09.5) | 2,885 | 1.1 (0.9–1.4) | 2.3 (1.8–2.8) | ||
| Norway | |||||||||
| Control | Fixed bearing | Any fixation | 19,580 | 51 (3) | 4.6 | 99.6 (99.4–99.8) | 4,127 | 1 (ref.) | |
| Study | Mobile bearing | Any fixation | 12,003 | 178 (15) | 97.2 (96.6–97.8) | 825 | 1.7 (1.4–2.0) | 6.0 (4.4–8.2) | |
| Non-keeled | Any fixation | 10,764 | 178 (17) | 4.4 | 97.1 (96.5–97.7) | 817 | 1.8 (1.5–2.3) | 6.2 (4.5–8.4) | |
| Cemented | 9,802 | 169 (17) | 4.5 | 97.1 (96.5–97.7) | 854 | 2.4 (1.8–3.1) | 6.4 (4.7–8.8) | ||
| Cementless | 914 | 9 (10) | 3.9 | 97.7 (94.9–100) | 73 | 0.7 (0.3–1.4) | 3.4 (1.7–7.0) | ||
| Keeled | Any fixation | 1,148 | 0 | 0.9 | – | – | – | – | |
| Cemented | 785 | 0 | 0.9 | – | – | – | – | ||
| Cementless | 363 | 0 | 0.9 | – | – | – | – | ||
| Duo-fix | Any fixation | 91 | 0 | 4.9 | – | – | – | – | |
| Cemented | 3 | 0 | 8.1 | – | – | – | – | ||
| Cementless | 88 | 0 | 4.9 | – | – | – | – |
Cementless compared with cemented non-keeled tibia components within Australia.
K–M = Kaplan–Meier. Cox RR1/RR2 = Cox regression risk estimates 1 and 2.
cat. no: 129431, 129432
cat. no: 129433, 129434
cat. no: 9003
10-year K–M survival data for revision due to aseptic loosening for the control groups, i.e. the 3 most common fixed bearing implants in each country
| Country | Subgroup | Tibial | Total (n) | Revised | Median | K–M survival | At risk (n) |
|---|---|---|---|---|---|---|---|
| Norway | |||||||
| Control | All | Any | 19,580 | 51 (3) | 4.6 | 99.6 (99.4–99.8) | 4,127 |
| Profix | Any | 12,611 | 27 (2) | 5.7 | 99.7 (99.5–99.9) | 3,401 | |
| NexGen | Any | 5,347 | 11 (2) | 1.2 | 99.6 (99.4–99.8) | 952 | |
| AGC | Any | 1,622 | 13 (8) | 6.6 | 99.0 (98.4–99.6) | 623 | |
| Australia | |||||||
| Control | All | Any | 48,173 | 195 (4) | 3.4 | 99.0 (98.8–99.2) | 1,170 |
| Triathlon | Any | 22,333 | 68 (3) | 3.1 | 99.4 (99.2–99.6) | 1,726 | |
| NexGen | Any | 16,609 | 76 (5) | 3.3 | 99.2 (99.0–99.4) | 1,459 | |
| PFC Sigma | |||||||
| fixed bearing | Any | 9,231 | 51 (6) | 4.9 | 98.9 (98.5–99.3) | 793 |
Figure 2.Kaplan–Meier curves with aseptic loosening as end-point. Mobile-bearing rotating-platform knees compared with fixed-bearing knees in Norway and Australia. (a) Mobile-bearing rotating-platform non-keeled knees (all fixations, without patella resurfacing) compared with the three most used fixed-bearing cruciate-retaining knees (all fixations, without patella resurfacing) in Norway. (b) Same selection criteria as above applied to Australian data.
Figure 3.Kaplan–Meier curves with aseptic loosening as end-point. Mobile-bearing rotating-platform non-keeled knees (all fixations, without patella resurfacing) in Norway and Australia, a comparison between countries.
Figure 4.Kaplan–Meier curves with aseptic loosening as end-point. Mobile-bearing rotating-platform non-keeled compared with keeled knees within Australia (Australian data only).
10-year K–M survival data and relative risk (RR) estimates by Cox regression analysis adjusting for age, sex, and preoperative diagnosis for revision due to any reason
| Country | Implant type | Tibial | Total (n) | Revised | Median | K–M survival | At risk (n) | Cox RR1 | Cox RR2 |
|---|---|---|---|---|---|---|---|---|---|
| Australia | |||||||||
| Control | Fixed bearing | Any | 48,173 | 1,071 | 3.4 | 95.9 (95.5–96.3) | 1,170 | 1 (ref.) | 1 (ref.) |
| Study | Mobile bearing | Any | 31,522 | 1,403 | 5.4 | 93.5 (93.1–93.9) | 2,723 | 1 (ref.) | 1.6 (1.5–1.7) |
| Norway | |||||||||
| Control | Fixed bearing | Any | 19,580 | 599 | 4.6 | 95.5 (95.1–95.9) | 1,737 | 1.2 (1.1–1.4) | 1 (ref.) |
| Study | Mobile bearing | Any | 12,003 | 495 | 4.1 | 93.0 (91.6–94.4) | 155 | 1.1 (1.0–1.2) | 1.4 (1.2–1.6) |
Cox regression risk estimates of Norwegian study or control group with corresponding Australian study or control group as reference
Number of revisions (n) by country and specified revision diagnosis, for the non-keeled mobile-bearing LCS Complete, hierarchical order from top to bottom. Values are number and percent of revisions
| Norway | Australia | Total | |
|---|---|---|---|
| Revision diagnosis | n = 10,763 | n = 15,415 | n = 26,178 |
| Not revised | 10,290 | 14,929 | 25,219 |
| Total number revised | 473 | 486 | 959 |
| Infection | 115 (24) | 78 (16) | 193 |
| Malalignment | 33 (7) | 8 (2) | 41 |
| Loosening/lysis | 178 (38) | 143 (29) | 321 |
| Instability | 47 (10) | 21 (4) | 68 |
| Pain only | 52 (11) | 122 (25) | 174 |
| Other reasons | 48 (10) | 114 (24) | 162 |